Probiotics: Time for a dose of realism

Current Issues in Intestinal Microbiology

Volumn 4, Issue 2, 2003, Pages 33-42

  Tannock, Gerald W ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; ATOPY; CLINICAL STUDY; CROHN DISEASE; DRUG DOSE REGIMEN; DRUG INFORMATION; DRUG LABELING; DRUG PACKAGING; ENTERITIS; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INTESTINE FLORA; LACTOBACILLUS; MEDICAL INFORMATION; NOMENCLATURE; NONHUMAN; ONLINE SYSTEM; SAFETY; SELF CARE; ULCERATIVE COLITIS;

DIGESTIVE SYSTEM; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; INFLAMMATORY BOWEL DISEASES; PROBIOTICS; SAFETY;

LACTOBACILLUS;

EID: 0141635240     PISSN: 1466531X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Alexander, M. 1971, Microbial ecology. John Wiley and Sons, New York.
2. Anon. 1998. New product reduces salmonellae in chickens. Journal of the American Veterinary Medicine Association 212: 1358.
3. Barrow, P. A., Brooker, B. E., Fuller, R. and Newport, M. J. 1980. The attachment of bacteria to the gastric epithelium of the pig and its importance in the microecology of the intestine. Journal of Applied Bacteriology 48: 147-154.
4. Berg, R. D. 1998. Probiotics, prebiotics or 'conbiotics'. Trends in Microbiology 6: 89-92.
5. Bjorksten, B., Naaber, P., Sepp, E. and Mikkelsaar, M. 1999. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clinical and Experimental Allergy 29: 342-346.
6. Bonhoff, M., Miller, C. P. and Martin, W. R. 1964a. Resistance of the mouse's intestinal tract to experimental Salmonella infection. I. Factors which interfere with the initiation of infection by oral inoculation. Journal of Experimental Medicine 120:805-816.
7. Bonhoff, M., Miller, C. P. and Martin, W. R. 1964b. Resistance of the mouse's intestinal tract to experimental Salmonella infection. II. Factors responsible for its loss following streptomycin treatment. Journal of Experimental Medicine 120: 817-828.
8. Chadwick, V. S. and Chen, W. 1999. The intestinal microflora and inflammatory bowel disease. In: Tannock, G. W. (ed), Medical importance of the normal microflora, pp. 177-221. Kluwer Academic Publishers, Dordrecht.
9. Cummings, J. H. and Macfarlane, G. T. 1991. The control and consequences of bacterial fermentation in the human colon. Journal of Bacteriology 70: 443-459.
10. D'Haens, G. R., Geboes, K., Peeters, M., Baert, F, Pennick, F. and Rutgeerts, P. 1998. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114: 262-267.
11. Drasar, B. S. and Hill, M. J. 1974. Human intestinal flora. Academic Press, London.
12. Duchmmann, R., Kaiser, I., Hermann, E., Mayet, W., Ewe, K. and Meyer zum Buschenfelde K. H. 1995. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clincal and Experimental Immunology 102: 448-455.
13. Farina, C., Arosio, M., Manguia, M. and Moioli, F. 2001. Lactobacillus casei subsp. rhamnosus sepsis in a patient with ulcerative colitis. Journal of Clinical Gastroenterology 33: 251-252.
14. Farooqi, I. S. and Hopkin, J. M. 1998. Early childhood infection and atopic disorder. Thorax 53: 927-932.
15. Finegold, S. M., Sutter, V. L. and Mathisen, G. E. 1983. Normal indigenous intestinal flora. In: Hentges, D. J. (ed), Human intestinal flora in health and disease, pp. 3-31. Academic Press, New York.
16. Franks, A. H., Harmsen, H. J., Raangs, G. C., Jansen, G. J., Schut, F. and Welling, G. W. 1998. Variation of bacterial populations in human faeces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Applied and Environmental Microbiology 64: 3336-3345.
17. Freter, R. 1988. Mechanisms of bacterial colonization of the mucosal surfaces of the gut. In: Virulence mechanisms of bacterial pathogens. Roth, J. A. (ed), pp. 45-60. American Society for Microbiology, Washington DC.
18. Fuller, R. 1989. Probiotics in man and animals. Journal of Applied Bacteriology 66: 365-378.
19. Fuller, R. 1999. Probiotics for farm animals. In: Tannock, G. W. (ed), Probiotics: a critical review, pp. 15-22. Horizon Scientific Press, Wymondham, UK.
20. Fuller, R. and Brooker, B. E. 1974. Lactobacilli which attach to the crop epithelium of the fowl. American Journal of Clinical Nutrition 27: 1305-1312.
21. Gill, H. S., Rutherofrd, K. J. and Cross, M. L. 2001. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. Journal of Clinical Immunology 21: 264-271.
22. Guarner, F. and Schaafsma, G. J. 1998. Probiotics. International Journal of Food Microbiology 39: 237-238.
23. Goldin, B. R and Gorbach, S. L. 1992. Probiotics for humans. In: Probiotics. The scientific basis, Fuller, R. (ed), pp. 355-376. Chapman and Hall, London.
24. Harmsen, H. J. M., Wildeboer-Veloo, A. C., Raangs, G. C., Wagendorp, A. A., Klijn, N., Bindels, J. G. and Welling, G. W. 2000. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification detection methods. Journal of Pediatric Gastroenterology and Nutrition 30: 61-67.
25. Hugot, J-P., Chamillard, M., Zouali, H., Lesage, S., Cezard, J. P., Belaiche, J., Almer, S., Tysk, C., Morain, C. A. et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
26. Husni, R. N., Gordon, S. M., Washington, J. A., and Longworth, D. L. 1997. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clinical Infectious Diseases 25: 1048-1055.
27. Kalliomaki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P. and Isolauri, E. 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076-1079.
28. Langendijk, P. S., Schut, F., Jansen, G. J., Raangs, G. C., Kamphuis, G. R., Wilinson, M. H. and Welling, G. W. 1995. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. With genus-specific 16S rRNA-targeted probes and its application in fecal samples. Applied and Environmental Microbiology 61: 3069-3075.
29. Lilley, D. M. and Stillwell, R. H. 1965. Probiotics: growth promoting factors produced by microorganisms. Science 147: 747-748.
30. Marteau, P., Pochart, P., Dore, J., Bera-Maillet, C., Bernalier, A. and Corthier, G. 2002. Comparative study of bacterial groups within the human cecal and fecal microbiota. Applied and Environmental Microbiology 67: 4939-4942.
31. McCracken, V. J. and Gaskins, H. R. 1999. Probiotics and the immune system. In: Tannock, G. W. (ed),), Probiotics: a critical review, pp. 85-111. Horizon Scientific Press, Wymondham, UK.
32. Metchnikoff, E. 1907. The prolongation of life. Optimistic studies. William Heinemann, London.
33. Metchnikoff, E. 1908. The nature of man. Studies in optimistic philosophy William Heinemann, London.
34. Meynell, G. G. 1963. Antibacterial mechanisms of the mouse gut: II. The role of Eh and volatile fatty acids in the normal gut. British Journal of Experimental Pathology 44: 209-219.
35. Morelli, L. 2000. In vitro selection of proiotic bactria: a critical appraisal. Current Issues In Intestinal Microbiology 1: 59-67.
36. Murray, C. S. and Woodcock, A. 2002. Gut microflora and atopic disease. In: Tannock, G. W. (ed), Probiotics and prebiotics: where are we going?, pp. 239-261. Caister Academic Press, Wymondham.
37. Naidu, A. S., Bidlack, W. R. and Clemens, R. A. 1999. Probiotic spectra of lactic acid bacteria (LAB). Critical Reviews in Food Science and Nutrition. 39: 13-126.
38. Ouwenhand, A., Isolauri, E. and Salminen, S. 2002. The role of the intestinal microflora for the development of the immune system in early childhood. European Journal of Nutrition 41 (Suppl. 1): I32-I37.
39. Parker, R. B. 1974. Probiotics, the other half of the antibiotic story. Animal Nutrition and Health 29: 4-8.
40. Rath, H. C., Wilson, K. H. and Sartor, R. B. 1999. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infection and Immunity 67: 2969-2974.
41. Rautio, M., Jousimes-Somer, H., Kauma, H., Pietarinen, I., Saxelin, M., Tynkkynen, S and Koskela, M. 1999. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clinical Infectious Diseases 28: 1160-1162.
42. Reid, G. 1999. Testing probiotics in clinical trials. In: Tannock, G. W. (ed), ), Probiotics: a critical review, pp. 129-140. Horizon Scientific Press, Wymondham, UK.
43. Rettger, L. F., Levy, W. N., Weinstein, L. and Weiss, J. E. 1935. Lactobacillus acidophilus and its therapeutic application. Yale University Press, New Haven.
44. Reuter, G. 2001. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Current Issues in Intestinal Microbiology 2: 43-53.
45. Salminen, S., Ouwehand, A., Benno, Y. and Lee, Y. K. 1999. Probiotics: how should they be defined. Trends in Food Science and Technology 10: 107-110.
46. Sanders, M. E. 1993. Effect of consumption of lactic cultures on human health. Advances in Food and Nutritional Research 37: 67-130.
47. Sanders, M. E. 2000. Considerations for use of probiotic bacteria to modulate human health. Journal of Nutrition 130: 384S-390S.
48. Savage, D. C. 1977. Microbial ecology of the gastrointestinal tract. Annual Review of Microbiology 31: 107-133.
49. Saavedra, J. M. 2000. Probiotics and infectious diarrhea. American Journal of Gastroenterology 95: S16-S18.
50. Schultz, M. and Rath, H. C. 2002. The possible role of probiotic therapy in inflammatory bowel disease, In: Tannock, G. W. (ed), Probiotics and prebiotics: where are we going?, pp. 239-261. Caister Academic Press, Wymondham.
51. Schultsz, C., Van den Berg, F. M., Ten Kate, F. W., Tygat, G. N. and Dankert, J. 1999. The intestinal mucus from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 117: 1089-1097.
52. Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M. and Sartor, R. B. 1998. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infection and Immunity 66: 5224-5231.
53. Sghir, A., Gramet, G., Suau, A., Rochet, V, Pochart, P. and Dore, J. 1995. Quantification of bacterial groups within the human fecal flora by oligonucleotide probe hybridization. Applied and Environmental Microbiology 66: 2263-2266.
54. Shanahan, F. 2001. Probiotics in inflammatory bowel disease. Gut 48: 609.
55. Sloan, E. 2001. Top 10 trends to watch and work on. Food Technology 55: 38-58.
56. Stebbings, S., Munro, K., Simon, M. A., Tannock, G. W. et al. 2002. Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology 41: 1395-1401.
57. Tannock, G.W. 1984. Control of gastrointestinal pathogens by normal flora. Klug, M. J. and Reddy C. A. (ed). In: Current Perspectives in Microbial Ecology, pp. 374-382. American Society for Microbiology, Washington DC. 374-382
58. Tannock, G. W. 1987. Demonstration of mucosa-associated microbial populations in the colons of mice. Applied and Environmental Microbiology 53: 1965-1968.
59. Tannock, G. W. 1995. The normal microflora. An introduction to microbes inhabiting the human body. Chapman and Hall, London.
60. Tannock, G. W. 1997. The normal microbiota of the gastrointestinal tract of rodents. In: Mackie, R. I., White, B. A. and Isaacson, R. E. (ed), Gastrointestinal microbiology, volume 2, Gastrointestinal microbes and host interactions, pp. 187-215. Chapman and Hall, New York.
61. Tannock, G. W., Munro, K., Harmsen, H. J. M., Welling, G. W., Smart, J. and Gopal, R K. 2000. Analysis of the fecal microflora of human subjects consuming a probiotic containing Lactobacillus rhamnosus DR20. Applied and Environmental Microbiology 66: 2578-2588.
62. Tissier, H. 1905. Repartition des microbes dans l'intestin du nourrisson. Annals of the Institute Pasteur, Paris 19: 109-123.
63. Van Heel, D. A., McGovern, P. B. and Jewell, D. P. 2001. Crohn's disease: genetic susceptibility, bacteria, and innate immunity. Lancet 357: 1902-1904.
64. Wagner, R. D., Warner, T., Roberta, L., Farmer, J. and Balish, E. 1997. Colonization of gengenitally immunodeficient mice with probiotic bacteria. Infection and Immunity 65: 3345-3351.
65. Woese, C. R. 1987. Bacterial evolution. Microbiological Reviews 51: 221-271.
66. Woo, P. C. Y., Fung, A. M. Y., Lau, S. K. P. and Yuen, K-Y. 2002. Identification by 16S rRNA gene sequencing of Lactobacillus salivarius bacteremic cholecystitis. Journal of Clinical Microbiology 40: 265-267.
67. Zoetendal, E., Akkermans, A. D. and De Vos, W. M. 1998. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Applied and Environmental Microbiology 64: 3854-3859.